OPDUALAG
Analogs of OPDUALAG
Find cheaper analogs and generic equivalents for OPDUALAG.
Active Ingredient: NIVOLUMAB, RELATLIMAB
Product Overview
About OPDUALAG
OPDUALAG is a prescription medication containing the active ingredients NIVOLUMAB and RELATLIMAB. It is used in the treatment of unresectable or metastatic melanoma, and in combination with other therapies, for the treatment of unresectable or metastatic non-small cell lung cancer.
Key Benefits & Uses
- Treatment of unresectable or metastatic melanoma
- Treatment of unresectable or metastatic non-small cell lung cancer in combination with other therapies
Active Ingredient & Action
NIVOLUMAB and RELATLIMAB are monoclonal antibodies that work by targeting and binding to specific proteins on cancer cells, helping to slow or stop the growth of the tumor. NIVOLUMAB targets the PD-1 protein, while RELATLIMAB targets the LAG-3 protein. By blocking these proteins, OPDUALAG helps the immune system to recognize and attack cancer cells.
Important Notes
OPDUALAG is a prescription medication and should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Common side effects may include fatigue, diarrhea, and skin rash. Patients with a history of immune-related adverse reactions or those taking other immunosuppressive medications should use OPDUALAG with caution.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.